Literature DB >> 26829312

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

Paul A Bunn1, John D Minna2, Alexander Augustyn2, Adi F Gazdar2, Youcef Ouadah3, Mark A Krasnow3, Anton Berns4, Elisabeth Brambilla5, Natasha Rekhtman6, Pierre P Massion7, Matthew Niederst8, Martin Peifer9, Jun Yokota10, Ramaswamy Govindan11, John T Poirier6, Lauren A Byers12, Murry W Wynes13, David G McFadden2, David MacPherson14, Christine L Hann15, Anna F Farago8, Caroline Dive16, Beverly A Teicher17, Craig D Peacock18, Jane E Johnson2, Melanie H Cobb2, Hans-Guido Wendel6, David Spigel19, Julien Sage3, Ping Yang20, M Catherine Pietanza6, Lee M Krug6, John Heymach12, Peter Ujhazy20, Caicun Zhou21, Koichi Goto22, Afshin Dowlati23, Camilla Laulund Christensen24, Keunchil Park25, Lawrence H Einhorn26, Martin J Edelman27, Giuseppe Giaccone28, David E Gerber2, Ravi Salgia29, Taofeek Owonikoko30, Shakun Malik17, Niki Karachaliou31, David R Gandara32, Ben J Slotman33, Fiona Blackhall34, Glenwood Goss35, Roman Thomas9, Charles M Rudin6, Fred R Hirsch36.   

Abstract

Entities:  

Keywords:  Gene mutations; Immunotherapy; Neuroendocrine; Small cell lung cancer; Therapy

Mesh：

Year:  2016        PMID： 26829312      PMCID： PMC4836290          DOI： 10.1016/j.jtho.2016.01.012

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  151 in total

1.  Nuclear factor I/B is an oncogene in small cell lung cancer.

Authors:  Alison L Dooley; Monte M Winslow; Derek Y Chiang; Shantanu Banerji; Nicolas Stransky; Talya L Dayton; Eric L Snyder; Stephanie Senna; Charles A Whittaker; Roderick T Bronson; Denise Crowley; Jordi Barretina; Levi Garraway; Matthew Meyerson; Tyler Jacks
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

2.  Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.

Authors:  Hidenobu Ishii; Koichi Azuma; Akihiko Kawahara; Kazuhiko Yamada; Yohei Imamura; Takaaki Tokito; Takashi Kinoshita; Masayoshi Kage; Tomoaki Hoshino
Journal:  J Thorac Oncol       Date:  2015-03       Impact factor: 15.609

3.  Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

Authors:  Neal E Ready; Herbert H Pang; Lin Gu; Gregory A Otterson; Sachdev P Thomas; Antonius A Miller; Maria Baggstrom; Gregory A Masters; Stephen L Graziano; Jeffrey Crawford; Jeffrey Bogart; Everett E Vokes
Journal:  J Clin Oncol       Date:  2015-03-02       Impact factor: 44.544

Review 4.  Targeted therapies for small cell lung cancer: Where do we stand?

Authors:  Alexandre Arcaro
Journal:  Crit Rev Oncol Hematol       Date:  2015-03-12       Impact factor: 6.312

5.  Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.

Authors:  Dong Xie; Randolph Marks; Mingrui Zhang; Gening Jiang; Aminah Jatoi; Yolanda I Garces; Aaron Mansfield; Julian Molina; Ping Yang
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

6.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

7.  NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.

Authors:  Jihan K Osborne; Jill E Larsen; Misty D Shields; Joshua X Gonzales; David S Shames; Mitsuo Sato; Ashwinikumar Kulkarni; Ignacio I Wistuba; Luc Girard; John D Minna; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

8.  Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells.

Authors:  Wendy K Roberts; Ilana J Deluca; Ashby Thomas; John Fak; Travis Williams; Noreen Buckley; Athanasios G Dousmanis; Jerome B Posner; Robert B Darnell
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

9.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

10.  Neuroendocrine cell populations in postnatal human lungs: minimal variation from childhood to old age.

Authors:  J R Gosney
Journal:  Anat Rec       Date:  1993-05
View more
  62 in total

1.  MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

Authors:  Gurkan Mollaoglu; Matthew R Guthrie; Stefanie Böhm; Johannes Brägelmann; Ismail Can; Paul M Ballieu; Annika Marx; Julie George; Christine Heinen; Milind D Chalishazar; Haixia Cheng; Abbie S Ireland; Kendall E Denning; Anandaroop Mukhopadhyay; Jeffery M Vahrenkamp; Kristofer C Berrett; Timothy L Mosbruger; Jun Wang; Jessica L Kohan; Mohamed E Salama; Benjamin L Witt; Martin Peifer; Roman K Thomas; Jason Gertz; Jane E Johnson; Adi F Gazdar; Robert J Wechsler-Reya; Martin L Sos; Trudy G Oliver
Journal:  Cancer Cell       Date:  2017-01-12       Impact factor: 31.743

Review 2.  Family matters: How MYC family oncogenes impact small cell lung cancer.

Authors:  Johannes Brägelmann; Stefanie Böhm; Matthew R Guthrie; Gurkan Mollaoglu; Trudy G Oliver; Martin L Sos
Journal:  Cell Cycle       Date:  2017-07-24       Impact factor: 4.534

3.  Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?

Authors:  Francesco Passiglia; Silvia Novello
Journal:  Ann Transl Med       Date:  2018-12

4.  Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.

Authors:  Miho Kono; Pamela K Allen; Steven H Lin; Xiong Wei; Melenda D Jeter; James W Welsh; James D Cox; Ritsuko Komaki
Journal:  J Thorac Oncol       Date:  2017-08-10       Impact factor: 15.609

5.  Recalcitrant small cell lung cancer: the argument for optimism.

Authors:  Karen G Zeman; Christina E Brzezniak; Corey A Carter
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Emerging strategies for the treatment of advanced small cell lung cancer.

Authors:  Joline S J Lim; Dearbhaile Collins; Timothy A Yap
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 7.  Immune checkpoint inhibitors and small cell lung cancer: what's new?

Authors:  Sabine Schmid; Martin Früh
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

8.  Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.

Authors:  Barbara A Helfrich; Jihye Kim; Dexiang Gao; Daniel C Chan; Zhiyong Zhang; Aik-Choon Tan; Paul A Bunn
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

9.  Opening a Chromatin Gate to Metastasis.

Authors:  John D Minna; Jane E Johnson
Journal:  Cell       Date:  2016-07-14       Impact factor: 41.582

10.  Unraveling the genomic complexity of small cell lung cancer.

Authors:  Niki Karachaliou; Aaron E Sosa; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.